GlassScriptPhysician profile
Martin N Wiseman
NPI 1508974445
$12,308.38
in general payments reported to CMS, 2019-2025
26 companies · $736 in 2025
The $736 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,250 · 2020: $253 · 2021: $671 · 2022: $2,841 · 2023: $4,505 · 2024: $1,051 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,433 · Travel and Lodging: $1,859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,433.39 |
| Travel and Lodging | $1,859.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,635.36 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $3,163.75 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Rhythmia Mapping System, Watchman Flx |
| Biosense Webster, INC. | $1,163.25 | 2019-2025 | Carto 3, Nuvision Ice Catheter |
| Impulse Dynamics (USA) INC. | $654.04 | 2022-2023 | Optimizer |
| Medtronic Vascular, INC. | $399.47 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $290.75 | 2019-2025 | Lifevest |
| Atricure, INC. | $178.40 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| E.R. Squibb & Sons, L.L.C. | $148.93 | 2019-2024 | Camzyos, Eliquis |
| Novo Nordisk INC | $120.63 | 2022-2024 | Wegovy |
| Abbott Laboratories | $115.20 | 2019-2023 | Gallant |
| Amgen INC. | $91.12 | 2019-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $70.06 | 2022-2023 | |
| Philips North America LLC | $52.53 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $29.80 | 2019-2022 | |
| Ekos Corporation | $23.99 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $22.98 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.38 | 2021 | |
| United Therapeutics Corporation | $16.94 | 2025 | Tyvaso |
| Astrazeneca Pharmaceuticals LP | $16.85 | 2023 | Brilinta |
| Regeneron Healthcare Solutions, INC. | $16.67 | 2019 | |
| Medtronic USA, INC. | $14.80 | 2019 | |
| Irhythm Technologies, INC. | $14.42 | 2019 | |
| Cardiovascular Systems INC. | $13.19 | 2023 | Diamondback Peripheral |
| Cvrx, INC. | $12.96 | 2023 | Barostim Neo System |
| Surmodics, INC. | $11.67 | 2024 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Teleflex LLC | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Wiseman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.